Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insulin sensitivity in relation to fat distribution and plasma adipocytokines among abusers of anabolic androgenic steroids
Jon Rasmussen, Morten Schou, Christian Selmer, et al.
Clinical Endocrinology (2017) Vol. 87, Iss. 3, pp. 249-256
Closed Access | Times Cited: 41

Showing 26-50 of 41 citing articles:

Off-label use of clomiphene citrate to treat anabolic androgenic steroid induced hypogonadism upon cessation among men (CloTASH) – A pilot study protocol
Ingrid Amalia Havnes, Hans Christian Bordado Henriksen, Per Wiik Johansen, et al.
MethodsX (2024) Vol. 13, pp. 102810-102810
Open Access | Times Cited: 1
Effect of Anabolic–Androgenic Steroid Abuse on the Contact Activation System
Johannes Jakobsen Sidelmann, Jørgen Gram, Yaseelan Palarasah, et al.
Thrombosis and Haemostasis (2021) Vol. 121, Iss. 10, pp. 1268-1273
Open Access | Times Cited: 8
The dichotomy between health and drug abuse in bodybuilding
Jay Horn
Nordic Studies on Alcohol and Drugs (2023) Vol. 41, Iss. 2, pp. 212-225
Open Access | Times Cited: 3
Extremely Low HDL Cholesterol and Increased LDL Cholesterol Induced by the use of Anabolic Steroids in a Body Builder: A Case Study
Min Li, Rabkin Simon W
International Journal of Sports and Exercise Medicine (2018) Vol. 4, Iss. 4
Open Access | Times Cited: 6
Challenges recruiting men with a desire to cease anabolic-androgenic steroid use to a pilot involving hormone therapy intervention
Hans Christian Bordado Henriksen, Anders Palmstrøm Jørgensen, Christine Wisløff, et al.
Drugs Education Prevention and Policy (2023) Vol. 31, Iss. 4, pp. 409-421
Open Access | Times Cited: 2
Correlation of serum adipocytokine levels with glycolipid metabolism and inflammatory factors in obese patients with periodontal disease.
Zejian Li, Chunting Lu, Jiayu Qiu, et al.
PubMed (2018) Vol. 11, Iss. 3, pp. 1620-1628
Closed Access | Times Cited: 5
Could Overt Diabetes Be Triggered by Abuse of Selective Androgen Receptor Modulators and Growth Hormone Secretagogues? A Case Report and Review of the Literature
Richard Sotorník, Roguel Suissa, Jean-Luc Ardilouze
Clinical Diabetes (2022) Vol. 40, Iss. 3, pp. 373-379
Open Access | Times Cited: 3
Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans
André Tchernof, Dannick Brochu, Ina Maltais‐Payette, et al.
Comprehensive physiology (2018) Vol. 8, Iss. 4, pp. 1253-1290
Closed Access | Times Cited: 3
Physical, psychological and biochemical recovery from anabolic steroid-induced hypogonadism: a scoping review
Pravik Solanki, Beng Eu, J. T. Smith, et al.
Endocrine Connections (2023) Vol. 12, Iss. 12
Open Access | Times Cited: 1
Off-label use of Clomiphene citrate to Treat Anabolic-androgenic Steroid induced Hypogonadism upon cessation among men (CloTASH) - a pilot study protocol
Ingrid Amalia Havnes, Hans Christian Bordado Henriksen, Per Wiik Johansen, et al.
Research Square (Research Square) (2024)
Open Access
Use of androgens at different stages of life: reproductive period
Andréa Prestes Nácul, Gabriela Pravatta Rezende, Daniela Angerame Yela, et al.
Revista Brasileira Ginecologia e Obstetrícia (2021) Vol. 43, Iss. 12, pp. 988-994
Open Access | Times Cited: 3
Circulating microRNAs in insulin resistant horses and ponies
Hugo Felipe da Costa Santos, Tanja Hess, Jason Brummer, et al.
Brazilian Journal of Veterinary Medicine/Revista Brasileira de Medicina Veterinária (2021) Vol. 43, pp. e003620-e003620
Open Access | Times Cited: 2
Discriminatory performance of adiponectin and leptin in the identification of impaired glucose tolerance: The Guangzhou Biobank Cohort Study - Cardiovascular Disease Subcohort
Konstantinos A. Toulis, Chao Qiang Jiang, Karla Hemming, et al.
PLoS ONE (2018) Vol. 13, Iss. 11, pp. e0206964-e0206964
Open Access | Times Cited: 1
Letter to the Editor: “Rate and Extent of Recovery from Reproductive and Cardiac Dysfunction Due to Androgen Abuse in Men”
Jon Rasmussen, Caroline Kistorp
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 8, pp. e3028-e3029
Open Access | Times Cited: 1
Will the use of anabolic androgenic steroids become a significant cardiovascular risk factor in the future?
Piotr Pawłucki, Anna Maciak, Ewelina Andrasz, et al.
Journal of Education Health and Sport (2023) Vol. 45, Iss. 1, pp. 269-283
Open Access
Influence of different training methods on cardiovascular disease risk markers after cessation of anabolic steroids abuse in bodybuilders at risk
Seyedeh Masumeh Hashemi, Hamid Arazi
Comparative Exercise Physiology (2021) Vol. 17, Iss. 4, pp. 331-341
Closed Access
Le dosage de l’Insulin-Like Growth Factor-1 : les difficultés de la détermination sérique et de l’interprétation des résultats
Meriem Gaddas
Nutrition Clinique et Métabolisme (2021) Vol. 36, Iss. 1, pp. 3-11
Closed Access
Previous Page - Page 2

Scroll to top